“ Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents ”, Arch Clin Psychiatry (former: Rev Psiq Clin), vol. 41, no. 2, pp. 34–39, Mar. 2014, doi: 10.1590/0101-60830000000007.